Next Article in Journal
New Insights into GFAP Negative Astrocytes in Calbindin D28k Immunoreactive Astrocytes
Next Article in Special Issue
JASPAC: Japan Spastic Paraplegia Research Consortium
Previous Article in Journal
Effect of Chronic Administration of Nickel on Affective and Cognitive Behavior in Male and Female Rats: Possible Implication of Oxidative Stress Pathway
Previous Article in Special Issue
Novel Type of Complicated Autosomal Dominant Hereditary Spastic Paraplegia Associated with Congenital Distal Arthrogryposis Type I
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Brain Sci. 2018, 8(8), 142; https://doi.org/10.3390/brainsci8080142

Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery

1
Department of Neurogenetics, Kolling Institute of Medical Research, The University of Sydney, Sydney, NSW 2065, Australia
2
Griffith Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia
*
Author to whom correspondence should be addressed.
Received: 15 June 2018 / Revised: 18 July 2018 / Accepted: 25 July 2018 / Published: 31 July 2018
(This article belongs to the Special Issue Advances in Genetics of Hereditary Spastic Paraplegia)
Full-Text   |   PDF [525 KB, uploaded 31 July 2018]   |  

Abstract

Hereditary spastic paraplegia is an inherited, progressive paralysis of the lower limbs first described by Adolph Strümpell in 1883 with a further detailed description of the disease by Maurice Lorrain in 1888. Today, more than 100 years after the first case of HSP was described, we still do not know how mutations in HSP genes lead to degeneration of the corticospinal motor neurons. This review describes how patient-derived stem cells contribute to understanding the disease mechanism at the cellular level and use this for discovery of potential new therapeutics, focusing on SPAST mutations, the most common cause of HSP. View Full-Text
Keywords: neurodegeneration; microtubule; organelle transport; peroxisome; spastic paraplegia; SPG4; SPAST; spastin neurodegeneration; microtubule; organelle transport; peroxisome; spastic paraplegia; SPG4; SPAST; spastin
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Wali, G.; Sue, C.M.; Mackay-Sim, A. Patient-Derived Stem Cell Models in SPAST HSP: Disease Modelling and Drug Discovery. Brain Sci. 2018, 8, 142.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Brain Sci. EISSN 2076-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top